Anthera Pharmaceuticals, Inc. (ANTH)
Stock Price: $0.116 USD
-0.055 (-32.06%)
Updated Feb 24, 2021 4:00 PM EST - Market closed
Market Cap | 399,773 |
Revenue (ttm) | n/a |
Net Income (ttm) | -24.93M |
Shares Out | 22.17M |
EPS (ttm) | -1.76 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Dividend Yield | n/a |
Trading Day | February 24 |
Last Price | $0.116 |
Previous Close | $0.170 |
Change ($) | -0.055 |
Change (%) | -32.06% |
Day's Open | 0.170 |
Day's Range | 0.101 - 0.170 |
Day's Volume | 972,188 |
52-Week Range | - |
News
There are no news available yet.
About ANTH
Anthera Pharmaceuticals, a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreem... [Read more...]
Industry Biotechnology | IPO Date Mar 1, 2010 |
CEO J. Craig Thompson | Employees 21 |
Stock Exchange OTCMKTS | Ticker Symbol ANTH |